Rallybio (RLYB)
Develops rare-disease therapies while pursuing a merger with oncology developer Avenzo.
$17.12
At close+0.43 (+2.58%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions38 holders · as of Mar 31, 2026 | 87.87% | 4.67M shares | |
| Insiders2 holders · as of Jul 10, 2026 | 0.20% | 10.7K shares | |
| Otherremainder | 11.93% | 633.4K shares |
5.31M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
Institutions13F, as of Mar 31, 2026
38 holders · 4.67M shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 793.5K | 14.94% | May 15, 2026 | |
| Viking Global Investors LP | 524.3K | 9.87% | May 15, 2026 | |
| Cormorant Asset Management, LP | 400.0K | 7.53% | May 15, 2026 | |
| TPG GP A, LLC | 378.6K | 7.13% | May 15, 2026 | |
| Balyasny Asset Management L.P. | 376.6K | 7.09% | May 15, 2026 | |
| Laurion Capital Management LP | 302.8K | 5.70% | May 14, 2026 | |
| Nantahala Capital Management, LLC | 300.6K | 5.66% | May 15, 2026 | |
| Pivotal Bioventure Partners Investment Advisor LLC | 300.6K | 5.66% | May 14, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 17.50% | 926.4K | 13G | Jun 5, 2026 ↗ |
| Viking Global Investors LP | 9.99% | 529.0K | 13G | May 15, 2026 ↗ |
| Cormorant Asset Management, LP | 7.56% | 400.0K | 13G | May 15, 2026 ↗ |
| TPG GP A, LLCincl. James G. Coulter, Jon Winkelried | 7.20% | 378.6K | 13D | Mar 3, 2026 ↗ |
| Balyasny Asset Management L.P. | 7.12% | 376.6K | 13G | May 15, 2026 ↗ |
| FMR LLC | 7.10% | 372.8K | 13G | Mar 6, 2026 ↗ |
| Laurion Capital Management LP | 5.72% | 302.8K | 13G | Apr 29, 2026 ↗ |
| Nantahala Capital Management, LLC | 5.68% | 300.6K | 13G | May 15, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 18, 2026 | ADAR1 Capital Management, LLC10 percent owner | Purchase | 6,009 | $13.98 | 916,152 |
| May 19, 2026 | ADAR1 Capital Management, LLC10 percent owner | Purchase · 2 lots | 10,200 | $13.98 | 926,352 |
| May 13, 2026 | ADAR1 Capital Management, LLC10 percent owner | Purchase · 2 lots | 79,259 | $13.99 | 909,843 |
| May 15, 2026 | ADAR1 Capital Management, LLC10 percent owner | Purchase · 2 lots | 300 | $13.90 | 910,143 |
| May 11, 2026 | ADAR1 Capital Management, LLC10 percent owner | Purchase · 3 lots | 50,000 | $14.00 | 829,784 |
| May 12, 2026 | ADAR1 Capital Management, LLC10 percent owner | Purchase | 800 | $13.83 | 830,584 |
| May 4, 2026 | ADAR1 Capital Management, LLC10 percent owner | Purchase · 2 lots | 120,804 | $13.97 | 744,683 |
| May 5, 2026 | ADAR1 Capital Management, LLC10 percent owner | Purchase | 35,101 | $14.00 | 779,784 |
| Feb 23, 2026 | Jonathan I. Lieberofficer: Chief Financial Officer | Sale | 789 | $5.06 | 4,115 |
CongressHouse and Senate disclosures
Not reported.
